The Macstrak Project CCU Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.

Slides:



Advertisements
Similar presentations
The Macstrak Project CCU Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
Advertisements

The Macstrak Project ER Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
The Macstrak Project ER Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
The Macstrak Project CCU Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
The Macstrak Project Ward Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
The Macstrak Project CCU Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
The Macstrak Project CCU Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
Keith A A Fox Royal Infirmary & University of Edinburgh CURE and PCI-CURE.
Treatment of Acute Coronary Syndrome with ST elevation ESC guidelines 2008 Dr. David Tran A&E dept. FVH 22/12/09.
CHEST PAIN Belgian Inter disciplinary Working group of Acute Cardiology Claeys MJ Vandekerckhove Y Bossaert L Calle P Martens P Hollanders G Vrints C Van.
“ If physicians would read two articles per day out of the six million medical articles published annually, in one year, they would fall 82 centuries behind.
The Macstrak Project CCU Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
The Macstrak Project ER Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
The Macstrak Project ER Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
Management of Acute Myocardial Infarction Minimal Acceptable vs Optimal Care Hussien H. Rizk, MD Cairo University.
A few basics of cardiac surgery…. Brett Sheridan, MD Assistant Professor Department of Surgery.
Current and Future Perspectives on Acute Coronary Syndromes Paul W. Armstrong MD AMI Quebec Montreal October 1, 2010.
Review cases 14-Apr SA is a 47 years old male who developed crushing substernal chest pain around 10 pm, he didn’t went to the hospital, in the.
Myocardial Infarction
The Macstrak Project Ward Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
lopidogrel in nstable Angina to Prevent ecurrent vents
Acute Coronary Syndrome. Acute Coronary Syndrome (ACS) Definition of ACS Signs and symptoms of ACS Gender and age related difference in ACS Pathophysiology.
1 Dr. Zahoor Ali Shaikh. 2 CORONARY ARTERY DISEASE (CAD)  CAD is most common form of heart disease and causes premature death.  In UK, 1 in 3 men and.
The Macstrak Project ER Case Studies The following is a series of case studies to review different patient types and how they are captured on the form.
‘Taxi Driver in Pain’ Tiara Gill Carrie Ross Mark Hambly.
CRUSADE: A National Quality Improvement Initiative CRUSADE: A National Quality Improvement Initiative Can Rapid Risk Stratification of Unstable Angina.
Chest Pain & Unstable Angina Eugene Yevstratov MD Based on UCLA protocol of the management of Chest Pain & Unstable Angina.
ACUTE CORONARY SYNDROME (ACS). ACS Pathophysiology is that of a ruptured or eroded atheromatous plaque. Pathophysiology is that of a ruptured or eroded.
VBWG OASIS-5 The Fifth Organization to Assess Strategies in Acute Ischemic Syndromes trial.
ACS and Thrombosis in the Emergency Setting
Tuesday Conference Myocardial Infarction Diagnosis and management.
Amy Gutman MD EMS Medication Director
DR. ZAHOOR 1.  A 50 year old man presents to clinic with a complaint of central chest discomfort of 2 weeks’ duration, occurring after walking for more.
APPROACH TO CHEST PAIN. OBJECTIVES  1. Establish a differential diagnosis for chest pain  2. Know what clues to obtain on history to rule-in or out.
ACS Clinical Pathway. Who? Pts with Acute Ischemic Heart Disease now described as having ACS.
Prasugrel vs. Clopidogrel for Acute Coronary Syndromes Patients Managed without Revascularization — the TRILOGY ACS trial On behalf of the TRILOGY ACS.
“The Doctor said another 5 minutes and I would have been dead” A regional approach to saving heart muscle Vanessa Thornton Clinical Head Emergency Care.
TREATMENT OF ACUTE MYOCARDIAL INFARCTION NUR 351/352 PROFESSOR DIANE E. WHITE RN MS CCRN.
Acute Coronary Syndrome
Diagnosis, Management, & Follow-up Care Of CAD/AMI BARRY BERTOLET, MD CARDIOLOGY ASSOCIATES OF NORTH MS.
The INT egrelin and E noxaparin R andomized assessment of A cute C oronary syndrome Treatment T rial Sponsored by the Canadian Heart Research Centre, Key.
Safer Healthcare Now! Acute Myocardial Infarction Presented by Amanda Thompson, Safer Healthcare Now Facilitator.
Acute Coronary Syndromes. Learning outcomes To understand the clinical spectrum of coronary disease To recognise different presentations of the disease.
Acute Coronary Syndrome David Aymond, MD. ACS Definition: Myocardial ischemia typically due to atherosclerotic plaque rupture  Coronary thrombosis ACS.
Acute Coronary Syndromes in West Hertfordshire Masood Khan.
Coronary Heart Disease (CHD) László Tornóci Inst. Pathophysiology Semmelweis University.
MYOCARDIAL INFARCTION. CASE 1 Mr. A: 38 years old He smokes 1 pack of cigarettes per day He has no other past medical history 8 hours ago, he gets sharp.
1 Advanced Angioplasty London, England 27 January, 2006 Jörg Michael Rustige,MD Medical Director Lilly Critical Care Europe, Geneva.
ADMIRALADMIRAL Abciximab before Direct Angioplasty and Stenting in Myocardial Infarction Regarding Acute and Long term follow-up ADMIRAL Study ADMIRAL.
VBWG OASIS-6 The Sixth Organization to Assess Strategies in Acute Ischemic Syndromes trial.
Acute Myocardial Infarction February 8, 2006.
Agrément FMC N° Conflits d’intérêt Astra-Zeneca, BMS, MSD, Novartis, Pfizer, Daiichi-Sankyo, Servier, CRAM, AFSSAPS, ARH Région de Bourgogne Clos.
{ Challenging Case Presentations From South Texas Methodist Hospital REGIONAL SYSTEMS OF CARE DEMONSTRATION PROJECT: MISSION: LIFELINE™ STEMI SYSTEMS ACCELERATOR.
A Clinical profile of patients enrolled in the Pakistan ACS registry
Chest Pain & Unstable Angina Eugene Yevstratov MD
CORONARY ARTERY DISEASE
T1: ACS Treatment Tutoring
Gender differences in the management of acute coronary syndrome patients: One year results from HPIAR (HP-India ACS Registry) Kunal Mahajan*, Negi PC,
Management of ST-Elevation Myocardial Infarction
ASSENT-3 PLUS 1,639 patients with STEMI Treatment Group A
CASE HISTORY ISCHEMIC HEART DISEASE
Ischaemic Heart Disease Acute Coronary Syndrome
R. Jay Widmer, MD, PhD, Peter M. Pollak, MD, Malcolm R
Chapter 28 Management of Patients With Coronary Vascular Disorders
Section A: Introduction
What oral antiplatelet therapy would you choose?
Infarct Size after Primary Angioplasty Patients With Bivalirudin
CRITICAL/CLINICAL PATHWAYS ACUTE CORONARY SYNDROMES
R. Jay Widmer, MD, PhD, Peter M. Pollak, MD, Malcolm R
Presentation transcript:

The Macstrak Project CCU Case Studies The following is a series of case studies to review different patient types and how they are captured on the form. The information is provided in sequence to reflect the natural progression of a patient’s care. As the case is presented, mark off the required information in the appropriate fields on your Macstrak form. At the end of each case study, the form will be reviewed with the correct answers supplied. If you have any questions, please refer to your Macstrak manual or contact us at the Macstrak Project Office.

The Macstrak Project CCU Case Study

The Macstrak Project CCU Case Study ENC is a 49-year-old (DOB: 27/04/56) working mom with no significant past medical history.

The Macstrak Project CCU Case Study On the morning of 02/03/06 ENC awakens at 05:00 with chest pain. She gets up and gets her children ready for daycare and drops them off. Rather than going to work she returns home and her husband calls an ambulance. The ambulance arrives at 07:50. At 08:05, en-route to the hospital, ENC has an ECG which shows ST elevation in II/IIIaVF. ASA is given to chew. She arrives at the ER at 08:25. She is seen by the triage RN on arrival and her vital signs are as follows: BP 130/70, HR 74 and chest is clear. ENC continues to have chest pain which she rates at 8/10. The ER MD assesses ENC and finds she has no contraindications to thrombolytic therapy. At 08:40 the decision is made to treat ENC (weight 62 kg) with TNK.

The Macstrak Project CCU Case Study 35 mg of TNK over 5 seconds is given at 08:50. ENC also receives UF heparin IV and metoprolol IV while in the ER. The pain resolves shortly after starting the TNK and the ST segments are normalising.

The Macstrak Project CCU Case Study 35 mg of TNK over 5 seconds is given at 08:50. ENC also receives UF heparin IV and metoprolol IV while in the ER. The pain resolves shortly after starting the TNK and the ST segments are normalising. ENC is admitted to your CCU that same morning with a diagnosis of Acute Myocardial Infarction. She has UF heparin infusing intravenously on arrival. Clopidogrel is started that evening. ENC has no further chest pain or complications while in CCU but her CK and troponin levels remain positive.

The Macstrak Project CCU Case Study ENC is transferred to a tertiary centre for a cath on 04/03/06 at 09:00. Her discharge diagnosis is Acute Myocardial Infarction and her peak CK is 1086, her peak troponin is 24. She is discharged on the following medications: ASA metoprolol clopidogrel UF heparin pravastatin

The Macstrak Project Centre: CCU ICU Date: 20 Day Month Year Patient Initials: F M L Birth Date: 19 Day Month Year Gender: Male Female CCU Case Study ENC is a 49-year-old (DOB: 27/04/56) working mom with no significant past medical history. E N C CCU MACSTRAK X

The Macstrak Project Centre: CCU ICU Date: 20 Day Month Year Patient Initials: F M L Birth Date: 19 Day Month Year Gender: Male Female CCU Case Study ENC is a 49-year-old (DOB: 27/04/56) working mom with no significant past medical history CCU MACSTRAK X On the morning of 02/03/06 ENC awakens at 05:00 with chest pain. She gets up and gets her children ready for daycare and drops them off. Rather than going to work she returns home and her husband calls an ambulance E N C

The Macstrak Project Past Medical History : 30 days MI ……………………………. Angina ……………………….. CABG ……………………….. PCI …………………………… CHF ………………………….. TIA/CVA …………………….. Diabetes (oral agents/insulin)... None of the Above……………. CCU Case Study ENC is a 49-year-old (DOB: 27/04/56) working mom with no significant past medical history. X

The Macstrak Project Patient Origin: ER EMS Walk In Dr.’s Office/Clinic (Direct) Other Hospital Inpatient Medical Ward Surgical Ward Other ICU Other: ……………… CCU Case Study On the morning of 02/03/06 ENC awakens at 05:00 with chest pain. She gets up and gets her children ready for daycare and drops them off. Rather than going to work she returns home and her husband calls an ambulance. The ambulance arrives at 07:50. At 08:05, en-route to the hospital, ENC has an ECG which shows ST elevation in II/IIIaVF. ASA is given to chew. She arrives at the ER at 08:25. X X

The Macstrak Project VS at Presentation: (complete for all patients) Dyspnea/Rales: None Mild Mod/Severe Systolic BP: < >190 Heart Rate: < >100 CCU Case Study She arrives at the ER at 08:25. She is seen by the triage RN on arrival and her vital signs are as follows: BP 130/70, HR 74 and chest is clear. ENC continues to have chest pain which she rates at 8/10. The ER MD assesses ENC and finds she has no contraindications to thrombolytic therapy. At 08:40 the decision is made to treat ENC (weight 62 kg) with TNK. X X X

The Macstrak Project CCU Case Study ENC is admitted to your CCU that same morning with a diagnosis of Acute Myocardial Infarction. She has UF heparin infusing intravenously on arrival. Clopidogrel is started that evening. ENC has no further chest pain or complications while in CCU but her CK and troponin levels remain positive. Admitting Diagnosis: (Check one only) Acute AMI (48 hrs) UA R/O MI UA RSCP NYD CHF Arrhythmia Aortic Dissection Non ACS Pericardial Disease Other: ………………… ACS X

The Macstrak Project CCU Case Study Symptom Onset : EMS at Scene: Timeline: (AMI pts only - 24 hr clock or > 24 hrs) Hospital Arrival: First ECG: EMS Diagnostic ECG: 0500 On the morning of 02/03/06 ENC awakens at 05:00 with chest pain. She gets up and gets her children ready for daycare and drops them off. Rather than going to work she returns home and her husband calls an ambulance. The ambulance arrives at 07:50. At 08:05, en-route to the hospital, ENC has an ECG which shows ST elevation in II/IIIaVF. ASA is given to chew. She arrives at the ER at 08: X 0805

The Macstrak Project Diagnostic ECG: (ACS pts. only) ST  ST  T  Q No ACS ST-TV 5-6 ……….… … ….. …... PacedII/IIIaVF ….. … ….. ….... OtherV 4 R..done... V 7-9..done... CCU Case Study V 1-4 ………….. …..… …... LBBB IaVL ………... ….…. …… The ambulance arrives at 07:50. At 08:05, en-route to the hospital, ENC has an ECG which shows ST elevation in II/IIIaVF. ASA is given to chew. She arrives at the ER at 08:25. X X

The Macstrak Project Reperfusion Therapy: No  Not Indicated:  ECG Not Diag. ST Up Transient Too Late Given (Other Hosp) Risk:  Risk of ICB Risk Other Bleed Other: …………… Drug:TNK/rtPA SK r-PA ( reteplase ) Other Adjuvant: ASA Heparin GP2b/3a Inhibitor  blocker IV Clopidogrel Other and/or Primary/Rescue PCI  Here Transfer Reperfusion Therapy Decided by:EP Consultant CCU Case Study Yes  Thrombolysis  Here EMS Other Hosp Dose: (mg/units) Duration: (min) Pt.Weight: (kg) The ER MD assesses ENC and finds she has no contraindications to thrombolytic therapy. At 08:40 the decision is made to treat ENC (weight 62 kg) with TNK. X X X X X 62

The Macstrak Project Reperfusion Therapy: No  Not Indicated:  ECG Not Diag. ST Up Transient Too Late Given (Other Hosp) Risk:  Risk of ICB Risk Other Bleed Other: …………… Drug:TNK/rtPA SK r-PA ( reteplase ) Other Adjuvant: ASA Heparin GP2b/3a Inhibitor  blocker IV Clopidogrel Other and/or Primary/Rescue PCI  Here Transfer Reperfusion Therapy Decided by:EP Consultant CCU Case Study Yes  Thrombolysis  Here EMS Other Hosp Dose: (mg/units) Duration: (min) Pt.Weight: (kg) The ambulance arrives at 07:50. At 08:05, en-route to the hospital, ENC has an ECG which shows ST elevation in II/IIIaVF. ASA is given to chew. X X X X X 62 X

The Macstrak Project Reperfusion Therapy: No  Not Indicated:  ECG Not Diag. ST Up Transient Too Late Given (Other Hosp) Risk:  Risk of ICB Risk Other Bleed Other: …………… Drug:TNK/rtPA SK r-PA ( reteplase ) Other Adjuvant: ASA Heparin GP2b/3a Inhibitor  blocker IV Clopidogrel Other and/or Primary/Rescue PCI  Here Transfer Reperfusion Therapy Decided by:EP Consultant CCU Case Study Yes  Thrombolysis  Here EMS Other Hosp Dose: (mg/units) Duration: (min) Pt.Weight: (kg) 35 mg of TNK over 5 seconds is given at 08:50. ENC also receives UF heparin IV and metoprolol IV while in the ER. The pain resolves shortly after starting the TNK and the ST segments are normalising. X X X X X X X X

The Macstrak Project CCU Case Study The ER MD assesses ENC and finds she has no contraindications to thrombolytic therapy. At 08:40 the decision is made to treat ENC (weight 62 kg) with TNK. TLysis Started: Arrive Lab: First Inflation: TLysis Ordered: GP 2b/3a Started: Transfer: 0840

The Macstrak Project CCU Case Study 35 mg of TNK over 5 seconds is given at 08:50. The ER MD assesses ENC and finds she has no contraindications to thrombolytic therapy. At 08:40 the decision is made to treat ENC (weight 62 kg) with TNK. TLysis Started: Arrive Lab: First Inflation: TLysis Ordered: GP 2b/3a Started: Transfer:

The Macstrak Project Acuity: Shift: Diuretics……………………… Inotropes IV………………….. ETT/Vent…………………….. PA Line………………………. TTVP………………………… IABP…………………………. ACS: RSCP - Ischemia – Definite…. – Probable… CK (+ve)………………...…… Troponin (+ve)……………….. NTG IV………………………. Heparin – UFH……………..... – LMWH……………. Other Antithrombin………...… GP 2b/3a Inhibitor IV……...… Clopidogrel (or ticlopidine)..… Cardiac Cath……………….... PCI…………………………... Outcomes: VF/Sustained VT………….… Infarction (new/repeat) *(1) …... Thrombolysis (new/repeat) *(2).. Stroke *(3) ……………………. Major Bleed *(4) ……………… Transfusion………………….. Crs1: ……………………….... Crs2: ……………………..….. None of the Above……….….. RN Initials ………………..…. Date: CCU Case Study DNDNN D ENC is admitted to your CCU that same morning with a diagnosis of Acute Myocardial Infarction. She has UF heparin infusing intravenously on arrival. Clopidogrel is started that evening. ENC has no further chest pain or complications while in CCU but her CK and troponin levels remain positive XXXXX KD AW XXX XX XX XXX XXX

The Macstrak Project Discharge Diagnosis: Acute MI Unstable Angina Chest Pain NYD CHF Arrhythmia Other Cardiac Problem: ………… Non Cardiac Problem: …..… ………..... Date: 20 Time: CCU Case Study ENC is transferred to a tertiary centre for a cath on 04/03/06 at 09:00. Her discharge diagnosis is Acute Myocardial Infarction and her peak CK is 1086, her peak troponin is 24. She is discharged on the following medications: ASA metoprolol clopidogrel UF heparin pravastatin Day Month Year Peak CK: Trop: X

The Macstrak Project CCU Case Study ENC is transferred to a tertiary centre for a cath on 04/03/06 at 09:00. Her discharge diagnosis is Acute Myocardial Infarction and her peak CK is 1086, her peak troponin is 24. She is discharged on the following medications: ASA metoprolol clopidogrel UF heparin pravastatin Discharged To: Cardiac Ward Med/Surg Ward Step Down Unit CV Surgery Other ICU Other Hospital Home Death Other: Discharge Meds: ASA Clopidogrel (or ticlop.) Heparin (UF or LMW) Nitrates (po/top) B Blocker ACEI A2 Blocker Statin None of Above X X X X X X